DAFTAR PUSTAKA

1) Seiter K. Acute Myeloid Leukemia (AML). Drugs and diseases [serial online] [edited

16 Mar 2021]. Available from: https://emedicine.medscape.com/article/197802-

overview

2) Vakiti A, Mewawalla P. Acute Myeloid Leukemia. InStatPearls [Internet] 2020 Nov 21.

StatPearls Publishing

3) Wintrobe MM. Wintrobe's clinical hematology. In: Lippincott Williams & Wilkins,

editor. Acute Myeloid Leukemia in Adults. 13th ed. Philadhelpia: Lippincott Williams &

Wilkins. 2001. PP 1577-1613

4) Walsh LR, Yuan C, Boothe JT, Conway HE, Mindiola-Romero AE, Barrett-Campbell

OO, Yerrabothala S, Lansigan F. Acute myeloid leukemia with hepatic infiltration

presenting as obstructive jaundice. Leukemia Research Reports. 2021 May 24:100251

5) Wang CX, Pusic I, Anadkat MJ. Association of leukemia cutis with survival in acute

myeloid leukemia. JAMA dermatology. 2019 Jul 1;155(7):826-32

6) WHO Expert Committee on the Selection, Use of Essential Medicines, World Health

Organization. The Selection and Use of Essential Medicines: Report of the WHO

Expert Committee, 2013 (including the 18th WHO Model List of Essential Medicines

and the 4th WHO Model List of Essential Medicines for Children). World Health

Organization; 2014.

7) Sambasivan A, Keely K, Mandel K, Johnston DL. Leukemia cutis: an unusual rash in a

child. Cmaj. 2010 Feb 9;182(2):171-3

8) Kawasaki T. Update on pediatric sepsis: a review. Journal of intensive care. 2017

Dec;5(1):1-2
9) Dewi W, Christie CD, Wardhana A, Fadhilah R, Pardede SO. Pediatric Logistic Organ

Dysfunction-2 (Pelod-2) score as a model for predicting mortality in pediatric burn

injury. Annals of burns and fire disasters. 2019 Jun 30;32(2):135

10)